Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jula Inrig currently holds 111,473 shares of Travere Therapeutics, Inc. (TVTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jula Inrig has been a net seller of TVTX stock. They have purchased $0 and sold $1.4M worth of shares.
Jula Inrig's most recent insider trade was on Apr 15, 2026, when they sold 1,018 shares at $42.61 per share.
Jula Inrig serves as Executive at Travere Therapeutics, Inc. (TVTX). They have executed 23 insider transactions totaling $1.4M over their tenure at the company.
Jula Inrig holds the position of Executive at Travere Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
Jula Inrig has shown a selling trading pattern, with $0 in total purchases and $1.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Jula Inrig was on Dec 24, 2025, when they sold $630.0K worth of TVTX shares. This transaction involved 15,000 shares at $42.00 per share.
Jula Inrig currently owns 111,473 shares of Travere Therapeutics, Inc. (TVTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jula Inrig's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jula Inrig has 23 Form 4 filings on record as an insider at Travere Therapeutics, Inc..
Set alerts for Jula Inrig and 40,000+ other insiders.